• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆增强心血管磁共振成像在安德森-法布里病中的应用。心肌间质疾病特异性异常的证据。

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

作者信息

Moon James C C, Sachdev Bhavesh, Elkington Andrew G, McKenna William J, Mehta Atul, Pennell Dudley J, Leed Philip J, Elliott Perry M

机构信息

Centre for Advanced Magnetic Resonance in Cardiology (CAMRIC), Royal Brompton Hospital, London, UK.

出版信息

Eur Heart J. 2003 Dec;24(23):2151-5. doi: 10.1016/j.ehj.2003.09.017.

DOI:10.1016/j.ehj.2003.09.017
PMID:14643276
Abstract

AIMS

Anderson-Fabry Disease (AFD), an X-linked disorder of sphingolipid metabolism, is a cause of idiopathic left ventricular hypertrophy but the mechanism of hypertrophy is poorly understood. Gadolinium enhanced cardiovascular magnetic resonance can detect focal myocardial fibrosis. We hypothesised that hyperenhancement would be present in AFD.

METHODS AND RESULTS

Eighteen males (mean 43+/-14 years) and eight female heterozygotes (mean 48+/-12 years) with AFD underwent cine and late gadolinium cardiovascular magnetic resonance. Nine male (50%) had myocardial hyperenhancement ranging from 3.4% to 20.6% (mean 7.7+/-5.7%) of total myocardium; in males, percentage hyperenhancement related to LV mass index (r=0.78, P=0.0002) but not to ejection fraction or left ventricular volumes. Lesser hyperenhancement was also found in four (50%) heterozygous females (mean 4.6%). In 12 (92%) patients with abnormal gadolinium uptake, hyperenhancement occurred in the basal infero-lateral wall where, unlike myocardial infarction, it was not sub-endocardial. In two male patients with severe LVH (left ventricular hypertrophy) and systolic impairment there was additional hyperenhancement in other myocardial segments.

CONCLUSIONS

These observations suggests that myocardial fibrosis occurs in AFD and may contribute to the hypertrophy and the natural history of the disease.

摘要

目的

安德森-法布里病(AFD)是一种X连锁的鞘脂代谢紊乱疾病,是特发性左心室肥厚的一个病因,但肥厚机制尚不清楚。钆增强心血管磁共振可检测局灶性心肌纤维化。我们推测AFD中会出现强化增强。

方法与结果

18例男性(平均43±14岁)和8例女性杂合子(平均48±12岁)AFD患者接受了电影和延迟钆心血管磁共振检查。9例男性(50%)出现心肌强化增强,范围为全心肌的3.4%至20.6%(平均7.7±5.7%);在男性中,强化增强百分比与左心室质量指数相关(r = 0.78,P = 0.0002),但与射血分数或左心室容积无关。在4例(50%)杂合子女性中也发现了较小程度的强化增强(平均4.6%)。在12例(92%)钆摄取异常的患者中,强化增强出现在基底下侧壁,与心肌梗死不同,此处不是心内膜下强化增强。在2例严重左心室肥厚(LVH)和收缩功能受损的男性患者中,其他心肌节段也有额外的强化增强。

结论

这些观察结果表明AFD中存在心肌纤维化,可能导致肥厚及疾病的自然病程。

相似文献

1
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.钆增强心血管磁共振成像在安德森-法布里病中的应用。心肌间质疾病特异性异常的证据。
Eur Heart J. 2003 Dec;24(23):2151-5. doi: 10.1016/j.ehj.2003.09.017.
2
Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.心血管磁共振显示安德森-法布里病的形态学表型谱和心肌瘢痕模式
J Cardiovasc Magn Reson. 2016 Mar 31;18:14. doi: 10.1186/s12968-016-0233-6.
3
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.应用心血管磁共振对比增强心肌 T1 mapping 技术对安德森-法布里病进行识别和评估。
Circ Cardiovasc Imaging. 2013 May 1;6(3):392-8. doi: 10.1161/CIRCIMAGING.112.000070. Epub 2013 Apr 5.
4
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.安德森-法布里病患者延迟钆增强心血管磁共振成像的组织学基础
J Cardiovasc Magn Reson. 2006;8(3):479-82. doi: 10.1080/10976640600605002.
5
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.法布瑞氏病患者的心肌纵向应变、心肌贮备和心肌肥厚。
Heart. 2019 Mar;105(6):470-476. doi: 10.1136/heartjnl-2018-313699. Epub 2018 Oct 3.
6
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.肌钙蛋白I突变所致肥厚型心肌病的心肌延迟钆增强心血管磁共振成像
Heart. 2005 Aug;91(8):1036-40. doi: 10.1136/hrt.2004.041384.
7
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.应用正电子发射断层扫描-磁共振成像技术评估安德森-法布里病患者不同阶段的心功能障碍:AFFINITY 研究组。
Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1004-1011. doi: 10.1093/ehjci/jez039.
8
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.使用对比增强磁共振成像来识别可逆性心肌功能障碍。
N Engl J Med. 2000 Nov 16;343(20):1445-53. doi: 10.1056/NEJM200011163432003.
9
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.法布里心肌病在男性和女性患者中的差异:对诊断评估的影响。
JACC Cardiovasc Imaging. 2011 Jun;4(6):592-601. doi: 10.1016/j.jcmg.2011.01.020.
10
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.二维斑点追踪作为一种无创工具用于鉴定法布里病心肌纤维化。
Eur Heart J. 2013 Jun;34(21):1587-96. doi: 10.1093/eurheartj/eht098. Epub 2013 Mar 21.

引用本文的文献

1
Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly.病例系列:老年人肥厚型心肌病的遗传模拟物
Front Cardiovasc Med. 2025 Jun 12;12:1483390. doi: 10.3389/fcvm.2025.1483390. eCollection 2025.
2
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies.法布里病:对病理生理学和新型治疗策略的见解
Biomedicines. 2025 Mar 4;13(3):624. doi: 10.3390/biomedicines13030624.
3
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies.推进心血管诊断:心脏磁共振成像在心力衰竭和心肌病中不断扩大的作用
J Clin Med. 2025 Jan 28;14(3):865. doi: 10.3390/jcm14030865.
4
Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta-analysis.法布里病心肌病不良预后的影像学预测指标:一项系统评价与荟萃分析。
Eur J Clin Invest. 2025 May;55(5):e14388. doi: 10.1111/eci.14388. Epub 2025 Jan 22.
5
Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures.肥厚型心肌病作为射血分数保留的心力衰竭的一种形式:诊断、药物及治疗方法
US Cardiol. 2024 Oct 14;18:e17. doi: 10.15420/usc.2023.21. eCollection 2024.
6
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.巴西心脏病学会和巴西放射学会心血管计算机断层扫描与磁共振成像指南 - 2024年
Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.
7
Strain rate during isovolumic relaxation as a prognostic biomarker for long-term cardiovascular morbidity and mortality: an exploratory study on a general population.等容舒张期应变率作为长期心血管疾病发病率和死亡率的预后生物标志物:一项针对普通人群的探索性研究。
J Echocardiogr. 2025 Jun;23(2):86-98. doi: 10.1007/s12574-024-00662-y. Epub 2024 Oct 15.
8
Cardiac involvement in Anderson-Fabry disease. The role of advanced echocardiography.心脏受累在安德森-法布里病中的情况。先进超声心动图的作用。
Front Cardiovasc Med. 2024 Sep 2;11:1440636. doi: 10.3389/fcvm.2024.1440636. eCollection 2024.
9
CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction.CMR 用于特征心力衰竭伴保留左心室射血分数患者的心肌结构和功能。
Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1491-1504. doi: 10.1093/ehjci/jeae224.
10
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification.法布里病的心脏磁共振特征:从早期诊断到预后分层
Rev Cardiovasc Med. 2022 May 16;23(5):177. doi: 10.31083/j.rcm2305177. eCollection 2022 May.